Dr Reddy's Laboratories' co-chairman and managing director, G V Prasad, talks with Scrip’s Anju Ghangurde about his conversations with late founder Dr Anji Reddy, the company’s “Horizon 2” trajectory, pricing expectations for CAR-T cell therapies, the promise of the China market, how Indian owner-managed pharma firms are figuring out ways to deal with succession issues and his new book.
https://scrip.citeline.com/SC149008/Dr-Reddys-MD-On-The-Next-Horizon-OwnerManaged-Firms-Birds-And-Beliefs